This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Current Discounted Rates End In:

  • 00
  • 00
  • 00
  • 00
Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Ravi Natarajan, Ph.D.
President at Socrates Biosciences


Dr. Ravi Natarajan completed a Post-doctoral fellowship in the laboratories of Professor K. C. Nicolaou at the Scripps Research Institute in La Jolla, California.   His Post-doctoral fellowship encompassed the “Total Synthesis of Vancomycin from basic starting materials”.  Prior to his post-doctoral fellowship, Dr. Ravi Natarajan completed his Doctorate in Organic Chemistry from the University of Illinois.  Dr. Natarajan started his research career as a medicinal chemist at Merck Research Laboratories in Rahway, NJ.  His tenure at Merck resulted in the discovery of 7 clinical candidates of which 3 advanced into phase-2 human clinical trials.  More recently Dr. Natarajan has joined hands with Professor Phil Baran to expand the applications of the P-V methodology (originally discovered in the Baran laboratories) to produce stereo-pure oligonucleotides and enable the oligonucleotide community to explore its therapeutic advantages.

Agenda Sessions

  • Practical Applications of P-V Methodology Towards the Synthesis of Stereo-pure Oligonucleotides